Human cytomegalovirus DNA kinetics using a novel HCMV DNA quantitative assay in white blood cells of immunocompromised patients under Ganciclovir therapy

Journal of Virological Methods

Volumn 65, Issue 1, 1997, Pages 131-138

  Payan, Christopher ^a   Veal, Nary ^a   Sarol, Lilen ^a   Villarmé, Mathieu ^a   Ngohou, Chan ^a   Riberi, Paul ^a   François, Sylvie ^a   Ifrah, Norbert ^a   Loison, Jocelyne ^a   Chennebault, Jean Marie ^a   Pichard, Eric ^a   Kouyoumdjian, Samuel ^a   Lunel, Francoise ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Ganciclovir treatment; GCV; HCMV DNA kinetics; pp65 antigenaemia

Indexed keywords

GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; VIRUS CHARACTERIZATION; VIRUS DETECTION;

ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; GANCICLOVIR; HUMANS; IMMUNOCOMPROMISED HOST; KINETICS; LEUKOCYTES; PHOSPHOPROTEINS; TIME FACTORS; VIRAL MATRIX PROTEINS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS; MUREX;

EID: 0030911857     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(97)02180-0     Document Type: Article

References (18)

1. Boeckh, M., Bowden, R.A., Goodrich, J.M. et al. (1992) Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 80, 1358-1364.
2. Bowen, E.F., Wilson, P., Atkins, M. et al. (1995) Natural history of untreated cytomegalovirus retinitis. Lancet 346, 1671-1673.
3. Bowen, E.F., Wilson, P., Cope, A. et al. (1996) Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival, AIDS 10, 1515-1520.
4. Drew, W.L., Miner, R.C., Bush, D.F. et al. (1991) Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J. Infect. Dis. 163, 716-719.
5. Field, A.K., and Biron, K.K. (1994) The end of innocence' revisited: Resistance of Herpesviruses to antiviral drugs. Clin. Microbiol. Rev. 7, 1-13.
6. Oerna, G., Parea, M., Percivalle, E. et al. (1990) Human cytomegalovirus viraemia in HIVl-seropositive patients at various clinical stages of infection. AIDS 4, 1027-1031.
7. Gerna, G., Zipeto, D., Parea, M. et al. (1991) Monitoring of human cytomegalovirus infection and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenaemia, and DNAemia. J. Infect. Dis. 164. 488-498.
8. Gerna, G., Sarasini, A., Percivalle, E. et al. (1995) Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples, J. Clin. Microbiol. 33, 738-741.
9. Goodrich, J.M., Mori, M., Cleaves, C.A. et al. (1991) Early treatment with ganciclovir to prevent cylomegalovirus disease after allogeneic bone marrow transplantation. N. Engl. J. Med. 325, 1601-1607.
10. Laurence, J. (1986) Cytomegalovirus infection in AIDS patients. Infect. Med. 3, 262-266.
11. Levin, M.J. (1993) Impact of Herpesvirus infections in the future. J. Med. Virol. (Suppl. 1) 158-164.
12. Pepin, J-M., Simon, F., Dussault, A. et al. (1992) Rapid determination of human cytoinegalovirus susceptibility to ganciclovir directly from clinical specimen primoculture. J. Clin. Microbiol. 30, 2917-2920.
13. Piketti, C., Bardin, C., Gilquin, J. et al. (1996) Low plasma concentrations achieved with conventional schedules of administration of ganciclovir in patients with AIDS. J. Infect. Dis. 174, 188-190.
14. Prosen, S., Kimel, V., Dawydowa, I. and Krûger, D. (1992) Monitoring of patients for cytomegalovirus after organ transplantation by centrifugation culture and PCR. J. Med. Virol. 38, 246-251.
15. Rubin, R.H. (1990) Impact of cytomegalovirus infection on organ transplant recipients. Rev. Infect. Dis. 7, S754-S766.
16. Veal, N., Payan, C., Fray, D. et al. (1996) Novel DNA assay for Cytomegalovirus detection: Comparison with conventional culture and pp65 antigenemia assay. J. Clin. Microbiol. 34. 3097-3100.
17. Yuen, G.J., Drusano, G.L., Fletcher, C. et al. (1995) Population differences in ganciclovir clearance as determined by nonlinear mixed-effects modelling. Antimicrob. Agents Chemother. 39, 2350-2352.
18. Zurlo, J.J., O'Neill, D., Polis, M,A., et al. (1993) Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann. Intern. Med. 118, 12-17.